GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arterra Bioscience SpA (MIL:ARBS) » Definitions » Total Liabilities

Arterra Bioscience SpA (MIL:ARBS) Total Liabilities : €1.94 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Arterra Bioscience SpA Total Liabilities?

Arterra Bioscience SpA's Total Liabilities for the quarter that ended in Jun. 2024 was €1.94 Mil.

Arterra Bioscience SpA's quarterly Total Liabilities declined from Jun. 2023 (€2.33 Mil) to Dec. 2023 (€1.80 Mil) but then increased from Dec. 2023 (€1.80 Mil) to Jun. 2024 (€1.94 Mil).

Arterra Bioscience SpA's annual Total Liabilities declined from Dec. 2021 (€2.11 Mil) to Dec. 2022 (€2.10 Mil) and declined from Dec. 2022 (€2.10 Mil) to Dec. 2023 (€1.80 Mil).


Arterra Bioscience SpA Total Liabilities Historical Data

The historical data trend for Arterra Bioscience SpA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arterra Bioscience SpA Total Liabilities Chart

Arterra Bioscience SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 2.44 2.14 2.11 2.10 1.80

Arterra Bioscience SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.18 2.10 2.33 1.80 1.94

Arterra Bioscience SpA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Arterra Bioscience SpA's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.843+(0.3+0.222
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.437+0)
=1.80

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=12.554-10.752
=1.80

Arterra Bioscience SpA's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.876+(0.3+0.282
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.48+0)
=1.94

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=12.541-10.603
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arterra Bioscience SpA Total Liabilities Related Terms

Thank you for viewing the detailed overview of Arterra Bioscience SpA's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Arterra Bioscience SpA Business Description

Traded in Other Exchanges
N/A
Address
via Benedetto Brin, 69, Napoli, ITA, 80142
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.

Arterra Bioscience SpA Headlines

No Headlines